On April 2, 2026, President Donald Trump issued a proclamation titled “Adjusting Imports of Pharmaceuticals and Pharmaceutical Ingredients into the United States” (the Proclamation) under Section 232 ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results